RBOT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
RBOT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
As of today, Vicarious Surgical's Trailing 12-Month Free Cash Flow is $-49.97 Mil, and Market Cap is $33.03 Mil. Therefore, Vicarious Surgical's FCF Yield % for today is -151.29%.
The historical rank and industry rank for Vicarious Surgical's FCF Yield % or its related term are showing as below:
Vicarious Surgical's FCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.
The historical data trend for Vicarious Surgical's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vicarious Surgical Annual Data | |||||||||||
Trend | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | ||||||
FCF Yield % | - | -2.72 | -26.18 | -99.41 | -64.36 |
Vicarious Surgical Quarterly Data | ||||||||||||||||||
Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
FCF Yield % | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
-77.12 | -109.05 | -127.79 | -151.25 | -60.53 |
For the Medical Devices subindustry, Vicarious Surgical's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Vicarious Surgical's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Vicarious Surgical's FCF Yield % falls into.
FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Vicarious Surgical's FCF Yield % for the fiscal year that ended in Dec. 2024 is calculated as
FCF Yield % | = | Free Cash Flow | / | Market Cap |
= | -50.136 | / | 77.89404 | |
= | -64.36% |
Vicarious Surgical's annualized FCF Yield % for the quarter that ended in Dec. 2024 is calculated as
FCF Yield % | = | Free Cash Flow | * | Annualized Factor | / | Market Cap |
= | -11.788 | * | 4 | / | 77.89404 | |
= | -60.53% |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vicarious Surgical FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Thank you for viewing the detailed overview of Vicarious Surgical's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
Adam David Sachs | director, 10 percent owner, officer: President and CEO | C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451 |
Sammy Khalifa | director, 10 percent owner, officer: Chief Technology Officer | C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451 |
William John Kelly | officer: CFO and Treasurer | C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451 |
John Mazzola | officer: Chief Operating Officer | TRANSMEDICS INC, 200 MINUTEMAN ROAD, ANDOVER MA 01810 |
June Morris | officer: CLO, General Counsel and Sec | C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451 |
Khosla Ventures Opportunity Ii, L.p. | 10 percent owner | 2128 SAND HILL ROAD, MENLO PARK CA 94025 |
Khosla Ventures Opportunity Associates Ii, Llc | 10 percent owner | 2128 SAND HILL ROAD, MENLO PARK CA 94025 |
Khosla Ventures V, L.p. | 10 percent owner | 2128 SAND HILL ROAD, MENLO PARK CA 94025 |
David D Ho | director | UNIT 1008, 10/F, CHAMPION TOWER, 3 GARDEN ROAD, CENTRAL K3 00000 |
Philip Liang | director | C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451 |
Brendel Victoria Carr | director | C/O VICARIOUS SURGICAL, INC., 78 FOURTH AVENUE, WALTHAM MA 02451 |
Beverly A Huss | director | C/O ACCURAY INCORPORATED, 1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089 |
Shrikant Patnaik | other: Principal | C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451 |
Ric Fulop | director | C/O DESKTOP METAL, INC., 63 THIRD AVENUE, BURLINGTON MA 01803 |
Barry Stuart Greene | 10 percent owner | C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451 |
From GuruFocus
By GuruFocus News • 11-13-2024
By Business Wire • 08-21-2024
By Business Wire • 03-13-2025
By GuruFocus News • 10-09-2024
By Business Wire • 02-18-2025
By Business Wire • 02-12-2024
By Business Wire • 07-29-2024
By Business Wire • 08-12-2024
By GuruFocus News • 10-09-2024
By Business Wire • 11-12-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.